Both malignancies are the most common cancer of the female, lymph node metastases indicate a poor prognosis, the hormonal status influences the development of CMT and estrogen receptor (ER), progesterone receptor (PR) and ERBB2 expression patterns do influence the overall survival rate [1,16-18]. The gene discussed is PGR; the disease is metastatic malignant neoplasm in the lymph nodes.